In conclusion, all of the above studies prove that elevated plasma levels of MIC-1/GDF-15 are significantly associated with cardiovascular diseases, cardiomyopathies, and pancreatic cancer. This evidence concerns the gene GDF15 and familial pancreatic carcinoma.